Alleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studies.

Michael A TsoukasElisa CohenLaurent LegaultJulia E von OettingenJean-François YaleMichael VallisMadison OdabassianAnas El FathiJoanna RutkowskiAdnan JafarMilad GhanbariNikita Gouchie-ProvencherJennifer RenéEmilie PalisaitisAhmad Haidar

Published in: Diabetes, obesity & metabolism (2021)

The FiASP-and-pramlintide system has the potential to substitute carbohydrate counting with SMA without degrading glucose control.

Keyphrases

blood glucose
study protocol
case control
human health
randomized controlled trial
clinical trial
risk assessment
type diabetes
metabolic syndrome
adipose tissue
skeletal muscle
weight loss
glycemic control
double blind